Related Experiment Videos
[Multifocal demyelinating neuropathy after tetanus vaccine]
G Paradiso1, F Micheli, M Fernández Pardal
1Hospital de Clínicas José de San Martin, Facultad de Medicina, Universidad de Buenos Aires, Argentina.
Abstract:
A 39 year old man presenting multifocal demyelinating neuropathy (MFDN) is reported. Fifteen days before onset he had been vaccinated with 75 IU of tetanus toxoid. Although recent histories of vaccination or viral infection support the immunological hypothesis proposed for chronic acquired demyelinating neuropathies (CADN) it is reported for the first time in MFDN, suggesting that MFDN and CADN may share common pathophysiological mechanisms.
Insights
A case study reports a 39-year-old man with multifocal demyelinating neuropathy (MFDN) following tetanus toxoid vaccination. This suggests MFDN and chronic acquired demyelinating neuropathies (CADN) may share similar underlying immune mechanisms.
Area of Science:
- Neurology
- Immunology
- Vaccinology
Background:
- Chronic acquired demyelinating neuropathies (CADN) are often linked to immune responses triggered by infections or vaccinations.
- The immunological basis for multifocal demyelinating neuropathy (MFDN) is less understood.
Observation:
- A 39-year-old male patient developed MFDN symptoms 15 days after receiving a tetanus toxoid vaccination.
Findings:
- This is the first reported case linking tetanus toxoid vaccination to the onset of MFDN.
- The temporal association suggests a potential vaccine-induced immune response.
Implications:
- MFDN and CADN might share common pathophysiological mechanisms involving immune system dysregulation.
- Further research into vaccine-associated demyelinating neuropathies is warranted.
- This case highlights the importance of considering vaccination history in MFDN diagnosis.